NCT01594762View on ClinicalTrials.gov

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Diabetic Foot Infection
Interventions
DRUG

Topical pexiganan cream 0.8%

14 days of treatment

DRUG

Topical placebo cream

14 days of treatment

OTHER

Standard wound care

14 days of treatment

Trial Locations (39)

Unknown

Phoenix

Tucson

Jonesboro

Castro Valley

Davis

Los Angeles

Napa

San Francisco

Santa Rosa

Sylmar

Vacaville

Norwalk

Coral Gables

Doral

Hialeah

Homestead

Jacksonville

Largo

Miami

Miami Lakes

Miami Shores

Pinellas Park

Evans

North Chicago

Hutchinson

New Orleans

Mineola

Charlotte

Wilmington

Duncansville

York

Columbia

El Paso

Fort Worth

Lewisville

Salt Lake City

St. George

Roanoke

Richland

Sponsors
All Listed Sponsors
lead

Dipexium Pharmaceuticals, Inc.

INDUSTRY